This condition is one of the main causes of heart diseases, such as myocardial infarction or cardiorespiratory arrest.

"VILPA may be a promising physical activity target for cardiovascular disease prevention, particularly in women unable or not ...

Deprescribing antihypertensive medication is not associated with the risk for hospitalization for myocardial infarction (MI) ...

Research on hormone therapy reveals critical insights into cardiovascular disease risks, guiding clinicians in selecting ...

Financially, Verve has a market cap of $475mn, cash balance of $540mn, and a cash runway of 7-8 quarters. Find out my ...

While chest pain is the most common heart attack symptom, there are various lesser-known red flags that are worth keeping an ...

BusinessWire India Mumbai Maharashtra [India] 3 SMT Sahajanand Medical Technologies a global leader in cardiovascular devices ...

After more than a decade of research, experts have revealed a worrying reality for people taking certain hormone medications ...

U.S. Renal Care Enrolled First Patients in the VOICE Collaborative Clinical Trial of Vafseo® (vadadustat) for CKD Patients on Dialysis ...

A new study supports previous data demonstrating the superiority of prasugrel over ticagrelor in reducing the composite ...

The 2023 AABB guidelines overall favor a restrictive transfusion strategy, recommending RBC transfusion for hemoglobin <7 ...